Truncating tau reveals different pathophysiological actions of oligomers in single neurons
Hill et al. examine the effects of full-length or truncated human recombinant tau on the excitability of hippocampal pyramidal neurons in mice. Their results suggest that effects seen with full-length tau oligomers can be dissected apart using tau truncations and highlights a tau-mediated alteration...
Enregistré dans:
Auteurs principaux: | Emily Hill, Thomas K. Karikari, Juan Lantero-Rodriguez, Henrik Zetterberg, Kaj Blennow, Magnus J. Richardson, Mark J. Wall |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/05b64a0a00e849388b47bc3893ecef99 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage
par: Lovisa Tobieson, et autres
Publié: (2021) -
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
par: Sherif Bayoumy, et autres
Publié: (2021) -
Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau Protein
par: Gaoping Lin, et autres
Publié: (2021) -
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome
par: Alberto Lleó, et autres
Publié: (2021) -
Formation and growth of oligomers: a Monte Carlo study of an amyloid tau fragment.
par: Da-Wei Li, et autres
Publié: (2008)